This week on Prof G Markets, Scott shares his thoughts on which stocks and sectors could get a boost or take a hit from Ozempic’s increasing popularity. Then, Josh Brown, CEO of Ritholtz Wealth, joins the show to help break down why bond yields have surged the past few weeks.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
View Original Article
Scott is the Founder of L2 and a Clinical Professor at the NYU Stern School of Business where he teaches brand strategy and digital marketing. In 2012, Professor Galloway was named “One of the World’s 50 Best Business School Professors” by Poets & Quants. He is also the founder of Red Envelope and Prophet Brand Strategy. Scott was elected to the World Economic Forum’s Global Leaders of Tomorrow and has served on the boards of directors of Eddie Bauer (Nasdaq: EBHI), The New York Times Company (NYSE: NYT), Gateway Computer, and UC Berkeley’s Haas School of Business. Scott co-hosts the Pivot podcast with Kara Swisher. He received a B.A. from UCLA and an M.B.A. from UC Berkeley.
https://scottgalloway.com/
Do you like The Prof G Show's articles? Follow on social!